U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with T

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138149 Q3 2022 TERT-BUTYL ALCOHOL INTRAVENOUS INJECTION 0.03 %w/v Deletion
138150 Q3 2022 TERT-BUTYL ALCOHOL SUBCUTANEOUS INJECTION 0.03 %w/v Deletion
138151 Q3 2022 TITANIUM DIOXIDE ORAL TABLET, COATED PARTICLES 15.00 mg 120mg Deletion
138152 Q3 2022 TRISODIUM CITRATE DIHYDRATE INTRAVENOUS LIQUID 0.36 %w/v Deletion
138153 Q3 2022 TRISODIUM CITRATE DIHYDRATE NASAL AEROSOL, SPRAY 17.00 mg Deletion
138525 Q2 2022 TALC ORAL CAPSULE, COATED, EXTENDED RELEASE 20.35 mg MDE Replacement
138526 Q3 2022 TALC ORAL CAPSULE, COATED, EXTENDED RELEASE 20mg MDE Replacement
138527 Q2 2022 TITANIUM DIOXIDE BUCCAL FILM 1.66 mg MDE Replacement
138528 Q3 2022 TITANIUM DIOXIDE BUCCAL FILM 3mg MDE Replacement
138529 Q2 2022 TITANIUM DIOXIDE ORAL CAPSULE 74.20 mg MDE Replacement
138530 Q3 2022 TITANIUM DIOXIDE ORAL CAPSULE 4mg MDE Replacement
138531 Q2 2022 TRIETHYL CITRATE ORAL CAPSULE, COATED, EXTENDED RELEASE 7.09 mg MDE Replacement
138532 Q3 2022 TRIETHYL CITRATE ORAL CAPSULE, COATED, EXTENDED RELEASE 7mg MDE Replacement
138533 Q2 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) TRANSDERMAL SYSTEM 44.51 mg MDE Replacement
138534 Q3 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) TRANSDERMAL SYSTEM 45mg MDE Replacement
138535 Q2 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S) TRANSDERMAL FILM, EXTENDED RELEASE 228.23 mg MDE Replacement
138536 Q3 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S) TRANSDERMAL FILM, EXTENDED RELEASE 704mg MDE Replacement
138537 Q2 2022 TRISODIUM CITRATE DIHYDRATE TOPICAL CLOTH 1.68 mg MDE Replacement
138538 Q3 2022 TRISODIUM CITRATE DIHYDRATE TOPICAL CLOTH 2mg MDE Replacement
138539 Q2 2022 TROLAMINE TOPICAL CREAM, AUGMENTED 1.00 %w/w MDE Replacement
138540 Q3 2022 TROLAMINE TOPICAL CREAM, AUGMENTED 20mg MDE Replacement
138541 Q2 2022 TROMETHAMINE INTRAVENOUS INJECTION, SOLUTION 1.21 %w/v MDE Replacement
138542 Q3 2022 TROMETHAMINE INTRAVENOUS INJECTION, SOLUTION 300mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top